Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Technology
Health care industry
Health & Science
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
Alzheimer's disease
Oil and Gas
World Markets
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
Daily Open
Eli Lilly and Co
Inflation
From
CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Health care industry
Breaking News: Business
Health & Science
From
CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
July 01, 2024
Tags
Investment strategy
Markets
Alnylam Pharmaceuticals Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Biotech and Pharmaceuticals
Science
Oracle Corp
From
CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
Eli Lilly and Co
Mad Money
Investing
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Novo Nordisk A/S
Europe News
Business
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Business
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Business
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Zealand Pharma A/S
Europe Markets
Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Health & Science
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Health care industry
Business
Novo Nordisk A/S
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Investing
Mad Money
Eli Lilly and Co
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Health care industry
Business
Health & Science
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
U/S/ Markets
stocks
Oracle Corp
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Health care industry
AstraZeneca PLC
Pfizer Inc
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Internet
Breaking News: Technology
Technology
From
CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
June 05, 2024
Tags
Alphabet Inc
Eli Lilly and Co
Technology
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Business News
Labor economy
Small Business: Management
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Companies
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Stock markets
Exchange/traded funds
Personal investing
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Hims & Hers Health Inc
Hospitals
Goldman Sachs Group Inc
From
CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
May 24, 2024
Tags
Biotech and Pharmaceuticals
Companies
US: News
From
CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
May 23, 2024
Tags
Business
Investment strategy
Sony Group Corp
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Fusion Pharmaceuticals Inc
Breaking News: Investing
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Healthy Returns
Uber Technologies Inc
Novo Nordisk A/S
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Biotech and Pharmaceuticals
Roche Holding AG
Carmot Therapeutics Inc
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Healthy Returns
Alphabet Inc
Novo Nordisk A/S
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Pharmaceuticals
Business News
Biotech and Pharmaceuticals
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.